$11.330
+0.393 (+3.47%)終値時点
INKT の同業比較
In the context of the broader market, INKT competes directly with industry leaders such as IMA and ELOX. With a market capitalization of $57.51M, it holds a significant position in the sector. When comparing efficiency, INKT's gross margin of N/A stands against IMA's N/A and ELOX's N/A. Such benchmarking helps identify whether Mink Therapeutics Inc is trading at a premium or discount relative to its financial performance.
Mink Therapeutics Inc の財務パフォーマンス
The company has been experiencing significant net losses, with Q2 2026 net loss at $3.1 million and a consistent negative EPS trend, with the latest at -0.62. The current ratio is 1.23, indicating some liquidity, but overall financial health appears weak.
Financials
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。